Close Menu

Caris

Movers & Shakers: Apr 8, 2011

Premium

Richard Bender

New Releases: Jan 19, 2011

Premium

Caris Target Now for Ovarian Cancer

Pairings : Jan 19, 2011

Premium

Sheila Walcoff, Amy Jensen Cunniffe, Gary Palmer

Movers & Shakers: Jan 14, 2011

Premium

Amy Jensen Cunniffe, Leonhard Pollack, Mark Pittman

Caris will exclusively offer Signal's Myeloma Prognostic Risk Signature, or MyPRS, test to community-based hematologists and medical oncologists across the US.

Pairings : Dec 8, 2010

Premium

Bernd Brust, Nicolas Barthelemy, Andy Tasinato, Elodie Ristorcelli, Gherici Hassaine, Dan Holterman, Wang-Juh Chen, Jorge Schettini, Tassilo Hornung

Movers & Shakers: Dec 3, 2010

Premium

Sven Beushausen, Andy Tasinato, Elodie Ristorcelli, Gherici Hassaine, Dan Holterman, Wang-Juh Chen, Jorge Schettini, Tasilo Hornung

Movers & Shakers: Nov 19, 2010

Premium

Jonathan Knowles

"The recent biomarker additions expand the potential clinical utility to include women who face therapeutic ambiguity earlier in the disease continuum -- a group representing nearly 50 percent of all breast cancer patients," the company said.

Movers & Shakers: Sep 10, 2010

Premium

Ian Walker, Ian Abercrombie, Stefan Gruenwald

Pages

Nature News examines how science in the UK may fare as Boris Johnson, the next prime minister, pursues Brexit.

CNN reports that Immigration and Customs Enforcement in the US has expanded its DNA testing to seven sites along the southern border.

In PNAS this week: role for exosomes in neuronal circuit development, tuberculosis pathogen enzymes, and more.

Undoing Obamacare protections could affect people's willingness to undergo genetic testing, Sarah Lawrence College's Laura Hercher and the University of Iowa College of Law's Anya Prince write at BuzzFeed News.